Get the Stockscreener App
263.51
5.59%
-15.59
After Hours:
263.51
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $263.51, with a volume of 1.49M.
It is down -5.59% in the last 24 hours and up +19.22% over the past month.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$279.10
Open:
$279.1
24h Volume:
1.49M
Relative Volume:
1.98
Market Cap:
$18.93B
Revenue:
$2.90B
Net Income/Loss:
$467.20M
P/E Ratio:
41.37
EPS:
6.37
Net Cash Flow:
$306.90M
1W Performance:
+24.95%
1M Performance:
+19.22%
6M Performance:
-23.62%
1Y Performance:
-4.92%
1-Day Range:
$261.00
$279.63
1-Week Range:
$208.71
$291.00
52-Week Range:
$187.43
$352.33
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
263.51 | 20.05B | 2.90B | 467.20M | 306.90M | 6.37 |
|
ISRG
Intuitive Surgical Inc
|
495.86 | 175.16B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
185.32 | 52.63B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
91.86 | 45.46B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
275.16 | 40.10B | 5.02B | 1.31B | 1.56B | 8.91 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
What catalysts could drive West Pharmaceutical Services Inc. stock higher in 2025Build a portfolio that grows with the market - jammulinksnews.com
What makes West Pharmaceutical Services Inc. stock price move sharplyInvest smarter with daily market updates - jammulinksnews.com
Does West Pharmaceutical Services Inc. stock perform well during market downturnsBreakthrough capital growth - jammulinksnews.com
What are analysts’ price targets for West Pharmaceutical Services Inc. in the next 12 monthsHigh-performance stocks for savvy investors - jammulinksnews.com
Should I hold or sell West Pharmaceutical Services Inc. stock in 2025Get alerts on the hottest market movers - jammulinksnews.com
How does West Pharmaceutical Services Inc. generate profit in a changing economyTake advantage of unprecedented market momentum - jammulinksnews.com
What are the technical indicators suggesting about West Pharmaceutical Services Inc.Unlock exclusive stock analysis for investors - jammulinksnews.com
How volatile is West Pharmaceutical Services Inc. stock compared to the marketBuild wealth faster with consistent investment plans - jammulinksnews.com
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? - Benzinga
West Pharmaceutical Services: Low Debt, High Profit, And A Waning Destocking Problem - Seeking Alpha
KeyBanc maintains Overweight rating on West Pharmaceutical stock - Investing.com
West Pharmaceutical: Q2 Earnings Snapshot - Erie News Now
S&P 500 Gains and Losses Today: West Pharmaceutical Services Stock Surges; Dow, LKQ Shares Fall - MSN
West Pharmaceutical Lifts Full-Year Forecast After Strong Q2 Performance - MSN
West Pharmaceutical Services Reports Strong Q2 2025 Results - The Globe and Mail
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MSN
De-Risking The Transition From Vial To Drug-Device Combination Product - Med Device Online
West Pharmaceutical Services, Inc.'s (NYSE:WST) Shares Climb 25% But Its Business Is Yet to Catch Up - simplywall.st
West Pharmaceutical rises on upbeat results, guidance raise - MSN
WST Stock Rises on Q2 Earnings Beat, EPS View Up on Tariff & FX Benefit - MSN
WST: UBS Raises Price Target for West Pharmaceutical Services | WST Stock News - GuruFocus
West Pharmaceutical Services Reports Strong Q2 Earnings, Surpassing ForecastsNews and Statistics - IndexBox
Lead Plaintiff Appointed in West Pharmaceutical Class Action - TradingView
A Quick Look at Today's Ratings for West Pharmaceutical Services(WST.US), With a Forecast Between $325 to $350 - 富途牛牛
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2025 Earnings Call Transcript - Insider Monkey
West Pharmaceutical Services (WST): A High-Margin Growth Story in the Evolving Pharma Packaging Sector - AInvest
West Pharmaceutical Services (WST) Surpasses Q2 Earnings and Revenue Estimates - Yahoo.co
Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks - MSN
Is West Pharmaceutical Services Inc. a good long term investmentHigh-profit capital plays - PrintWeekIndia
West Pharmaceutical Services Inc (WST) Q2 2025 Earnings Call Highlights: Strong Growth in ... By GuruFocus - Investing.com Canada
West Pharmaceutical Services Inc. Stock Analysis and ForecastAccelerated wealth building - PrintWeekIndia
WST Q2 Deep Dive: High-Value Product Momentum Drives Guidance Increase - TradingView
West Pharmaceutical Services’ Earnings Call Highlights Strong Growth - TipRanks
Stock Movers: West Pharma, Chipotle, Southwest - Bloomberg.com
West Pharmaceutical Services Q2 2025 Earnings Report - MarketBeat
West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings - MSN
McMahon Takes Over: What’s Next for West Pharmaceutical? - timothysykes.com
Medical Name Bolts Higher On 'Unexpectedly' Strong Earnings - Investor's Business Daily
U.S. Indexes Finished Mixed Thursday As West Pharmaceutical Svcs Led, Dow Lagged - Barron's
West Pharmaceutical Services raises 2025 revenue guidance to $3.04B–$3.06B as HVP components accelerate - MSN
West Pharma Lifts Forecast As GLP-1 Demand Drives Results - Finimize
West Pharmaceutical’s New CFO: Market Impact? - timothysykes.com
Tesla, IBM Slide; West Pharma Soars Among Thursday’s Market Cap Stock Movers - Investing.com Nigeria
West Pharmaceutical Services Q2 2025: Navigating Contradictions in Growth, Automation, and Revenue Dynamics - AInvest
West Pharmaceutical Services, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:WST) - Seeking Alpha
West Pharma EPS Jumps 22 Percent in Q2 - The Globe and Mail
West Pharma EPS Jumps 22 Percent in Q2 - The Motley Fool
Why Are West Pharmaceutical Services (WST) Shares Soaring Today - Yahoo Finance
West Pharmaceutical Lifts Forecast As Demand For Drug Components Rises - Finimize
West Pharmaceutical stock price target raised to $350 from $275 at Evercore ISI - Investing.com UK
West Pharmaceutical Services: Leveraging HVP Growth and Regulatory Tailwinds for Long-Term Value Creation - AInvest
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):